Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCX-1000 in Portal Hypertension
NCT00414869Phase 2Terminated
- Sponsor
- Forest Laboratories
- Start
- Nov 2005
- Primary completion
- Feb 2007
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of NCX-1000 in Portal Hypertension (PH), sponsored by Forest Laboratories. Started Nov 2005; status: terminated.
02
Drugs
NCX-1000
03
Conditions
Portal Hypertension (PH)
Beyond the preview
Go deeper on NCT00414869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414869.